GlassScriptPhysician profile
Christopher S Kunz
NPI 1750438669
$1,615.50
in general payments reported to CMS, 2019-2025
11 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $318 · 2023: $522 · 2024: $179 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $315.28 | 2023-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $287.24 | 2023-2025 | |
| Atricure, INC. | $270.81 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Abiomed | $231.19 | 2022-2025 | Impella |
| Janssen Pharmaceuticals, INC | $158.53 | 2021-2023 | Xarelto |
| Novocure INC. | $150.24 | 2023 | Optune |
| Ethicon US, LLC | $112.59 | 2023-2025 | Vistaseal, Ethicon, Stratafix |
| Medtronic, INC. | $33.13 | 2025 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals LP | $19.67 | 2022 | |
| Amgen INC. | $18.47 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.35 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kunz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.